Skip to content
  • 6,813 federal solicitations are open right now. How many of them are yours?
  • New solicitations are posted every day. The ones you never saw are the ones you cannot win.
  • Stop checking SAM.gov every morning. Let the contracts that fit your business come to you.
  • Tell Abierto what you sell in one sentence. AI reads every open solicitation for you.
  • Deadlines are short. Hear about a solicitation the day it is posted, not the week it closes.
  • Amendments move deadlines. Watch a solicitation and Abierto tells you when it changes.
  • See which contracts in your field are about to end, and who holds them today.
  • Plans from $39 a month. See your matches before you pay.
See plans
AbiertoGet started

Solicitation

Olink Explorer >5400

75N98026Q00800

National Institutes of Health, National Institutes of Health Olao. Testing Laboratories and Services.

Response deadline

July 25, 2026 at 9:00 AM EDT

Closed 99 days ago. Posted July 15, 2026. Scheduled to archive July 26, 2026.

Get the next one like this from National Institutes of Health by email, the day it is posted.Find my opportunities

This one closed in 2026

23 like it are open now in testing laboratories and services

All 23 open in testing laboratories and services

Description

As published on SAM.gov.

Requirements:

2.0       BACKGROUND 

Our lab studies the role of inflammation/innate resistance and commensal microbiota in carcinogenesis, cancer progression and therapy of cancer. 

The following product features/characteristics are required for this requirement:  

Protein Coverage - Measures ~5,400+ human proteins simultaneously in a single workflow. 

Technology - Uses Proximity Extension Assay (PEA) with dual antibody recognition coupled to DNA barcoding and next-generation sequencing (NGS) readout. 

Sample input – requires only 2 ul of plasma, serum, and other sample types 

Specificity - Reported 99.5% specificity with negligible cross-reactivity due to dual-recognition antibody design. 

Dynamic Range - Approximately 10 orders of magnitude (fg/mL to mg/mL), enabling detection of both low- and high-abundance proteins. 

Key strengths 

  • Very broad proteome coverage while maintaining antibody-based specificity.  
  • Excellent sensitivity for low-abundance circulating proteins (especially cytokines and signaling proteins).  
  • Extremely low sample-volume requirement.  
  • Highly standardized platform, making it attractive for epidemiology and multi-omics studies.

Attachments

Files listed on SAM.gov. The ones we hold a copy of download from here; the rest open SAM's download, which needs no account.

Publications

Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.

  1. July 15, 2026

    Solicitation

    Due July 25, 2026 at 9:00 AM EDT. SAM.gov, notice 0bcdbebf6ffc4be299a63e6ac5baa36f

    1 revisions on SAM
    • July 15, 2026: publish, solicitation

Points of contact